Growth in this antimicrobial susceptibility testing market is primarily driven by the rising incidence of infectious diseases; technological advancements towards the development of rapid AST technologies; increased funding, research grants, and public-private investments; growing government initiatives to detect and control antimicrobial-resistant species; and the emergence of multidrug resistance due to drug abuse. However, the high cost of automated antimicrobial susceptibility testing systems is expected to limit market growth in the coming years. Complex regulatory frameworks that delay the approval of new microbial susceptibility tests are also expected to challenge market growth to a certain extent.
According to research report the global antimicrobial susceptibility testing market size is projected to reach USD 4.2 billion by 2025 from USD 3.2 billion in 2020, at a CAGR of 5.5% during the forecast period.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=206359984
By identifying over 30,000+ growth opportunities through our unique market research methodology, markets and markets help grow your business, drive market performance and assess potential business disruptors.
The market is segmented by by Product (Manual, Automated Susceptibility Testing System), Type (Antibacterial, Antifungal), Application (Clinical Diagnostics), Method (ETEST, Disk Diffusion), End-User Region
Based on the product, the antimicrobial susceptibility testing market is segmented into automated laboratory instruments, culture and growth media, manual antimicrobial susceptibility testing products and consumables. The manual susceptibility testing products segment is further divided into susceptibility testing disks, MIC strips, and susceptibility testing plates. Among the manual antimicrobial susceptibility testing products, the susceptibility testing disks segment held a major share of the market in 2019. The high quality, low cost, and ease of use of these products are increasing the adoption of susceptibility testing disks in emerging countries. Some prominent players offering susceptibility testing disks include BD (US), Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories, Inc. (US), and HiMedia Laboratories (India).
Based on type, the antimicrobial susceptibility testing market has been segmented into the antibacterial susceptibility testing, antiparasitic susceptibility testing, antifungal susceptibility testing and susceptibility testing types. Among these, the antibacterial susceptibility testing segment dominated the market in 2019. The major share of the segment is attributed to the presence of regulatory guidelines to streamline the process of antibacterial susceptibility testing, technological advancements, and the rising burden of antibacterial resistance in developing as well as developed countries.
Based on application, the Antibiotic susceptibility testing market has been segmented into the antimicrobial susceptibility testing market is segmented into drug discovery and development, clinical diagnostics, epidemiology, and other applications. Significant market growth in the clinical diagnostics segment can be attributed to the rising burden of infectious diseases, the growing burden of antimicrobial resistance, and new product launches in the market.
The competitive landscape includes the analysis of the key growth strategies adopted by major players between 2017–2020 to expand their global presence and increase their market shares in the antimicrobial susceptibility testing market. The key growth strategies adopted by the top players in the market include product launches and approvals, agreements, expansions, and acquisitions. Product approvals and launches were the most widely adopted growth strategies by market players in the last three years to garner a larger share of the market. In 2019, the Antibiotic susceptibility testing market was dominated by bioMérieux SA (France), Becton, Dickinson and Company (US), Thermo Fisher Scientific (US), Danaher Corporation (US), and Bio-Rad Laboratories, Inc. (US).
Request For Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=206359984
bioMérieux SA (France) is a leader in the global AST market. bioMérieux is a developer of innovative solutions for clinical diagnostics and industrial microbiological control in fields such as the agri-food sector, environmental monitoring, and veterinary diagnostics. The comprehensive range of products, high focus on RD (to deliver novel products in the market), and strong geographical presence are the key factors contributing to the major market share of the company in the AST market.
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441